ChemomAb Competitors and Similar CompaniesClear all

ChemomAb's competitors and similar companies include Autolus and Altimmune.
ChemomAb
ChemomAb
ChemomAb is a clinical stage biopharmaceutical company which develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Altimmune
Altimmune
Altimmune is a clinical-stage immunotherapeutics company.
Founding Date
Founding Date
2010
Founding Date
2014
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tel Aviv-Yafo, IL HQ
Locations
London, GB HQ
London, GB
Locations
Gaithersburg, US HQ
Employees
Employees
N/A
Employees
647
Employees
691% increase
Valuation ($)
Valuation ($)
28.1 m
Valuation ($)
1.2 b
Valuation ($)
498.2 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$75.4m (FY, 2025)
Revenue (est.)
$41k (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$86.6m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
($10.7m) (FY, 2025)
Gross profit
N/A
Net income
Net income
($9m) (FY, 2025)
Net income
($287.5m) (FY, 2025)
Net income
($88.1m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 15m
Total funding raised
$ 281.7m
Total funding raised
$ 47.7m
For sources of this data, please see the company profile

View Company Profiles

Autolus
HQ
London, GB
Employees
647

Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.

View company
Altimmune
HQ
Gaithersburg, US
Employees
69↑ 1% increase

Altimmune is a clinical-stage immunotherapeutics company.

View company